Fulgent Genetics (NASDAQ:FLGT – Free Report) had its price target decreased by Piper Sandler from $28.00 to $25.00 in a research note released on Wednesday morning, Benzinga reports. Piper Sandler currently has a neutral rating on the stock. Separately, UBS Group started coverage on Fulgent Genetics in a research report on Thursday, December 7th. They […]
Full Year 2023 Total Revenue of $289.2 million; Q4 2023 Total Revenue of $70.5 million
Full Year 2023 Core Revenue grows 44% year-over-year to $262.1 million; Q4 2023 Core Revenue grows 21%.
Fulgent Genetics (NASDAQ:FLGT) Shares Down 7 8% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
North American Morning Briefing: Stock Futures -2- morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.